TCTC Holdings’s Merck MRK Stock Holding History

TCTC Holdings’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$24.8M	Buy	206,456 +4,664	+2%	+$538K	0.71%	35
2025 Q4	$21.2M	Sell	201,792 -1,271	-0.6%	-$119K	0.63%	40
2025 Q3	$17M	Buy	203,063 +185	+0.1%	+$15.2K	0.51%	47
2025 Q2	$16.1M	Buy	202,878 +2,354	+1%	+$187K	0.52%	45
2025 Q1	$18M	Buy	200,524 +155	+0.1%	+$14.5K	0.63%	41
2024 Q4	$19.9M	Buy	200,369 +627	+0.3%	+$64.6K	0.72%	39
2024 Q3	$22.7M	Buy	199,742 +3,256	+2%	+$387K	0.77%	33
2024 Q2	$24.3M	Sell	196,486 -2,066	-1%	-$266K	0.84%	30
2024 Q1	$26.2M	Buy	198,552 +1,079	+0.5%	+$133K	0.87%	30
2023 Q4	$21.5M	Buy	197,473 +893	+0.5%	+$92.7K	0.79%	35
2023 Q3	$20.2M	Buy	196,580 +209	+0.1%	+$22.5K	0.78%	33
2023 Q2	$22.7M	Buy	196,371 +120	+0.1%	+$13.6K	0.9%	31
2023 Q1	$20.9M	Buy	196,251 +6,855	+4%	+$740K	0.84%	31
2022 Q4	$21M	Sell	189,396 -2,644	-1%	-$270K	0.86%	30
2022 Q3	$16.5M	Buy	192,040 +150	+0.1%	+$13.4K	0.72%	33
2022 Q2	$17.5M	Sell	191,890 -2,869	-1%	-$254K	0.77%	34
2022 Q1	$16M	Sell	194,759 -539	-0.3%	-$42.5K	0.66%	40
2021 Q4	$15M	Buy	195,298 +957	+0.5%	+$76.2K	0.64%	43
2021 Q3	$14.6M	Buy	194,341 +275	+0.1%	+$20.9K	0.67%	41
2021 Q2	$15.1M	Sell	194,066 -9,799	-5%	-$729K	0.69%	42
2021 Q1	$15M	Buy	203,865 +628	+0.3%	+$46.3K	0.71%	41
2020 Q4	$15.9M	Buy	203,237 +1,981	+1%	+$152K	0.85%	34
2020 Q3	$15.9M	Buy	201,256 +152	+0.1%	+$11.9K	0.98%	31
2020 Q2	$14.8M	Sell	201,104 -12,061	-6%	-$908K	0.88%	35
2020 Q1	$15.6M	Buy	213,165 +1,386	+0.7%	+$109K	1.18%	23
2019 Q4	$18.4M	Sell	211,779 -2,410	-1%	-$198K	0.94%	28
2019 Q3	$17.2M	Sell	214,189 -446	-0.2%	-$35.7K	0.9%	27
2019 Q2	$17.2M	Sell	214,635 -1,408	-0.7%	-$108K	0.94%	29
2019 Q1	$17.1M	Hold	216,043	–	–	0.93%	28
2018 Q4	$15.8M	Buy	216,043 +608	+0.3%	+$42.9K	0.88%	29
2018 Q3	$14.6M	Sell	215,435 -970	-0.4%	-$61.8K	0.67%	34
2018 Q2	$12.5M	Sell	216,405 -1,484	-0.7%	-$83.7K	0.61%	34
2018 Q1	$11.3M	Buy	217,889 +3,590	+2%	+$194K	0.6%	35
2017 Q4	$11.5M	Sell	214,299 -771	-0.4%	-$42.7K	0.6%	37
2017 Q3	$13.1M	Sell	215,070 -455	-0.2%	-$27.6K	0.81%	31
2017 Q2	$13.2M	Buy	215,525 +2,468	+1%	+$150K	0.9%	30
2017 Q1	$12.9M	Sell	213,057 -261	-0.1%	-$15.8K	0.79%	36
2016 Q4	$12M	Sell	213,318 -5,058	-2%	-$296K	0.73%	38
2016 Q3	$13M	Buy	218,376 +609	+0.3%	+$35.6K	0.95%	29
2016 Q2	$12M	Buy	217,767 +2,653	+1%	+$141K	0.81%	34
2016 Q1	$10.9M	Buy	215,114 +3,658	+2%	+$179K	0.68%	36
2015 Q4	$10.7M	Sell	211,456 -419	-0.2%	-$21.1K	0.64%	34
2015 Q3	$9.99M	Buy	211,875 +7,127	+3%	+$379K	0.57%	35
2015 Q2	$11.1M	Buy	204,748 +1,834	+0.9%	+$103K	0.64%	36
2015 Q1	$11.1M	Buy	202,914 +2,830	+1%	+$160K	0.66%	33
2014 Q4	$10.8M	Hold	200,084	–	–	0.66%	37
2014 Q3	$11.3M	Buy	200,084 +372	+0.2%	+$20.9K	0.65%	33
2014 Q2	$11M	Hold	199,712	–	–	0.7%	29
2014 Q1	$10.8M	Buy	199,712 +643	+0.3%	+$33.3K	0.62%	34
2013 Q4	$9.51M	Buy	199,069 +295	+0.1%	+$13.5K	0.54%	38
2013 Q3	$9.03M	Buy	198,774 +6,220	+3%	+$284K	0.58%	35
2013 Q2	$8.53M	Buy	+192,554	New	+$8.6M	0.56%	34

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TCTC Holdings's MRK Position: Q1 2026 in Review

TCTC Holdings increased its Merck (MRK) stake by 2.3% in Q1 2026, buying an estimated $538K and bringing the position to 206,456 shares worth $24.8M. The position accounts for 0.71% of the portfolio, ranked #35.

TCTC Holdings first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $26.2M in Q1 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

TCTC Holdings held 206,456 shares of Merck worth $24.8M as of Q1 2026.
TCTC Holdings bought 4,664 Merck shares in Q1 2026, an estimated $538K.
Merck made up 0.71% of TCTC Holdings's portfolio in Q1 2026, its #35 holding.
TCTC Holdings first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
TCTC Holdings's Merck position peaked at $26.2M in Q1 2024.
3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on TCTC Holdings's 13F filing for Q1 2026, filed 7 May 2026.